nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ALB—melanoma	0.232	0.512	CbGaD
Prednisone—ABCB1—melanoma	0.221	0.488	CbGaD
Prednisone—ALB—Vemurafenib—melanoma	0.117	0.397	CbGbCtD
Prednisone—CYP3A4—Temozolomide—melanoma	0.0669	0.227	CbGbCtD
Prednisone—ABCB1—Dactinomycin—melanoma	0.0407	0.138	CbGbCtD
Prednisone—CYP3A4—Vemurafenib—melanoma	0.0367	0.124	CbGbCtD
Prednisone—ABCB1—Docetaxel—melanoma	0.021	0.0712	CbGbCtD
Prednisone—CYP3A4—Docetaxel—melanoma	0.0126	0.0427	CbGbCtD
Prednisone—Dry skin—Temozolomide—melanoma	0.000474	0.00315	CcSEcCtD
Prednisone—Muscular weakness—Carmustine—melanoma	0.000472	0.00314	CcSEcCtD
Prednisone—Hypokalaemia—Temozolomide—melanoma	0.00047	0.00313	CcSEcCtD
Prednisone—Acute coronary syndrome—Bleomycin—melanoma	0.000466	0.0031	CcSEcCtD
Prednisone—Myocardial infarction—Bleomycin—melanoma	0.000463	0.00308	CcSEcCtD
Prednisone—Neutropenia—Dactinomycin—melanoma	0.000462	0.00307	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Temozolomide—melanoma	0.000456	0.00303	CcSEcCtD
Prednisone—Muscular weakness—Temozolomide—melanoma	0.000456	0.00303	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000453	0.00301	CcSEcCtD
Prednisone—Skin exfoliation—Docetaxel—melanoma	0.000452	0.00301	CcSEcCtD
Prednisone—Abdominal distension—Temozolomide—melanoma	0.00045	0.00299	CcSEcCtD
Prednisone—Fluid retention—Docetaxel—melanoma	0.00045	0.00299	CcSEcCtD
Prednisone—Neuropathy—Docetaxel—melanoma	0.000445	0.00296	CcSEcCtD
Prednisone—Sweating increased—Temozolomide—melanoma	0.000435	0.0029	CcSEcCtD
Prednisone—Oesophagitis—Docetaxel—melanoma	0.000433	0.00288	CcSEcCtD
Prednisone—Neutropenia—Carmustine—melanoma	0.000432	0.00288	CcSEcCtD
Prednisone—Decreased appetite—Vemurafenib—melanoma	0.000432	0.00287	CcSEcCtD
Prednisone—Fatigue—Vemurafenib—melanoma	0.000429	0.00285	CcSEcCtD
Prednisone—Haemoglobin—Bleomycin—melanoma	0.000426	0.00283	CcSEcCtD
Prednisone—Constipation—Vemurafenib—melanoma	0.000425	0.00283	CcSEcCtD
Prednisone—Haemorrhage—Bleomycin—melanoma	0.000424	0.00282	CcSEcCtD
Prednisone—Pulmonary oedema—Docetaxel—melanoma	0.000422	0.0028	CcSEcCtD
Prednisone—Neutropenia—Temozolomide—melanoma	0.000418	0.00278	CcSEcCtD
Prednisone—Hyperglycaemia—Carmustine—melanoma	0.000417	0.00277	CcSEcCtD
Prednisone—Erectile dysfunction—Temozolomide—melanoma	0.000411	0.00274	CcSEcCtD
Prednisone—Depression—Carmustine—melanoma	0.000411	0.00273	CcSEcCtD
Prednisone—Sepsis—Docetaxel—melanoma	0.000411	0.00273	CcSEcCtD
Prednisone—Weight increased—Temozolomide—melanoma	0.000407	0.0027	CcSEcCtD
Prednisone—Weight decreased—Temozolomide—melanoma	0.000404	0.00269	CcSEcCtD
Prednisone—Neuropathy peripheral—Carmustine—melanoma	0.000404	0.00269	CcSEcCtD
Prednisone—Hyperglycaemia—Temozolomide—melanoma	0.000403	0.00268	CcSEcCtD
Prednisone—Depression—Temozolomide—melanoma	0.000397	0.00264	CcSEcCtD
Prednisone—Thrombophlebitis—Docetaxel—melanoma	0.000397	0.00264	CcSEcCtD
Prednisone—Flushing—Bleomycin—melanoma	0.000393	0.00262	CcSEcCtD
Prednisone—Body temperature increased—Vemurafenib—melanoma	0.000393	0.00261	CcSEcCtD
Prednisone—Neuropathy peripheral—Temozolomide—melanoma	0.00039	0.0026	CcSEcCtD
Prednisone—Cardiac failure congestive—Docetaxel—melanoma	0.000379	0.00252	CcSEcCtD
Prednisone—Alopecia—Bleomycin—melanoma	0.000375	0.00249	CcSEcCtD
Prednisone—Haemoglobin—Carmustine—melanoma	0.000372	0.00247	CcSEcCtD
Prednisone—Haemorrhage—Carmustine—melanoma	0.00037	0.00246	CcSEcCtD
Prednisone—Erythema—Bleomycin—melanoma	0.000369	0.00245	CcSEcCtD
Prednisone—Hallucination—Carmustine—melanoma	0.000368	0.00245	CcSEcCtD
Prednisone—Flushing—Dactinomycin—melanoma	0.000367	0.00244	CcSEcCtD
Prednisone—Hypersensitivity—Vemurafenib—melanoma	0.000366	0.00244	CcSEcCtD
Prednisone—Connective tissue disorder—Carmustine—melanoma	0.000364	0.00242	CcSEcCtD
Prednisone—Haemoglobin—Temozolomide—melanoma	0.000359	0.00239	CcSEcCtD
Prednisone—Haemorrhage—Temozolomide—melanoma	0.000358	0.00238	CcSEcCtD
Prednisone—Asthenia—Vemurafenib—melanoma	0.000357	0.00237	CcSEcCtD
Prednisone—Hallucination—Temozolomide—melanoma	0.000356	0.00237	CcSEcCtD
Prednisone—Cardiac failure—Docetaxel—melanoma	0.000352	0.00234	CcSEcCtD
Prednisone—Pruritus—Vemurafenib—melanoma	0.000352	0.00234	CcSEcCtD
Prednisone—Connective tissue disorder—Temozolomide—melanoma	0.000351	0.00234	CcSEcCtD
Prednisone—Lethargy—Docetaxel—melanoma	0.000351	0.00233	CcSEcCtD
Prednisone—Alopecia—Dactinomycin—melanoma	0.000349	0.00232	CcSEcCtD
Prednisone—Eye disorder—Carmustine—melanoma	0.000346	0.0023	CcSEcCtD
Prednisone—Erythema—Dactinomycin—melanoma	0.000344	0.00229	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000344	0.00229	CcSEcCtD
Prednisone—Flushing—Carmustine—melanoma	0.000343	0.00228	CcSEcCtD
Prednisone—Ill-defined disorder—Bleomycin—melanoma	0.000342	0.00228	CcSEcCtD
Prednisone—Anaemia—Bleomycin—melanoma	0.000341	0.00227	CcSEcCtD
Prednisone—Diarrhoea—Vemurafenib—melanoma	0.00034	0.00226	CcSEcCtD
Prednisone—Eye disorder—Temozolomide—melanoma	0.000334	0.00222	CcSEcCtD
Prednisone—Malaise—Bleomycin—melanoma	0.000333	0.00221	CcSEcCtD
Prednisone—Flushing—Temozolomide—melanoma	0.000332	0.00221	CcSEcCtD
Prednisone—Arrhythmia—Carmustine—melanoma	0.000331	0.0022	CcSEcCtD
Prednisone—Dizziness—Vemurafenib—melanoma	0.000329	0.00219	CcSEcCtD
Prednisone—Alopecia—Carmustine—melanoma	0.000327	0.00218	CcSEcCtD
Prednisone—Angiopathy—Temozolomide—melanoma	0.000324	0.00216	CcSEcCtD
Prednisone—Mental disorder—Carmustine—melanoma	0.000324	0.00216	CcSEcCtD
Prednisone—Immune system disorder—Temozolomide—melanoma	0.000323	0.00215	CcSEcCtD
Prednisone—Erythema—Carmustine—melanoma	0.000322	0.00214	CcSEcCtD
Prednisone—Malnutrition—Carmustine—melanoma	0.000322	0.00214	CcSEcCtD
Prednisone—Ill-defined disorder—Dactinomycin—melanoma	0.000319	0.00212	CcSEcCtD
Prednisone—Anaemia—Dactinomycin—melanoma	0.000318	0.00212	CcSEcCtD
Prednisone—Vomiting—Vemurafenib—melanoma	0.000316	0.0021	CcSEcCtD
Prednisone—Alopecia—Temozolomide—melanoma	0.000316	0.0021	CcSEcCtD
Prednisone—Dry skin—Docetaxel—melanoma	0.000315	0.0021	CcSEcCtD
Prednisone—Myalgia—Bleomycin—melanoma	0.000314	0.00209	CcSEcCtD
Prednisone—Rash—Vemurafenib—melanoma	0.000313	0.00209	CcSEcCtD
Prednisone—Mental disorder—Temozolomide—melanoma	0.000313	0.00208	CcSEcCtD
Prednisone—Dermatitis—Vemurafenib—melanoma	0.000313	0.00208	CcSEcCtD
Prednisone—Headache—Vemurafenib—melanoma	0.000311	0.00207	CcSEcCtD
Prednisone—Erythema—Temozolomide—melanoma	0.000311	0.00207	CcSEcCtD
Prednisone—Malnutrition—Temozolomide—melanoma	0.000311	0.00207	CcSEcCtD
Prednisone—Discomfort—Bleomycin—melanoma	0.00031	0.00207	CcSEcCtD
Prednisone—Malaise—Dactinomycin—melanoma	0.00031	0.00206	CcSEcCtD
Prednisone—Vision blurred—Carmustine—melanoma	0.000304	0.00202	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Docetaxel—melanoma	0.000303	0.00202	CcSEcCtD
Prednisone—Anaphylactic shock—Bleomycin—melanoma	0.000301	0.002	CcSEcCtD
Prednisone—Oedema—Bleomycin—melanoma	0.000301	0.002	CcSEcCtD
Prednisone—Infection—Bleomycin—melanoma	0.000299	0.00199	CcSEcCtD
Prednisone—Anaemia—Carmustine—melanoma	0.000298	0.00198	CcSEcCtD
Prednisone—Agitation—Carmustine—melanoma	0.000296	0.00197	CcSEcCtD
Prednisone—Nausea—Vemurafenib—melanoma	0.000295	0.00196	CcSEcCtD
Prednisone—Vision blurred—Temozolomide—melanoma	0.000293	0.00195	CcSEcCtD
Prednisone—Myalgia—Dactinomycin—melanoma	0.000293	0.00195	CcSEcCtD
Prednisone—Discomfort—Dactinomycin—melanoma	0.00029	0.00193	CcSEcCtD
Prednisone—Ill-defined disorder—Temozolomide—melanoma	0.000289	0.00192	CcSEcCtD
Prednisone—Anaemia—Temozolomide—melanoma	0.000288	0.00191	CcSEcCtD
Prednisone—Anorexia—Bleomycin—melanoma	0.000287	0.00191	CcSEcCtD
Prednisone—Agitation—Temozolomide—melanoma	0.000286	0.0019	CcSEcCtD
Prednisone—Angioedema—Temozolomide—melanoma	0.000284	0.00189	CcSEcCtD
Prednisone—Oedema—Dactinomycin—melanoma	0.000281	0.00187	CcSEcCtD
Prednisone—Malaise—Temozolomide—melanoma	0.000281	0.00187	CcSEcCtD
Prednisone—Vertigo—Temozolomide—melanoma	0.00028	0.00186	CcSEcCtD
Prednisone—Convulsion—Carmustine—melanoma	0.000279	0.00186	CcSEcCtD
Prednisone—Infection—Dactinomycin—melanoma	0.000279	0.00186	CcSEcCtD
Prednisone—Hypertension—Carmustine—melanoma	0.000278	0.00185	CcSEcCtD
Prednisone—Neutropenia—Docetaxel—melanoma	0.000278	0.00185	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000274	0.00183	CcSEcCtD
Prednisone—Myalgia—Carmustine—melanoma	0.000274	0.00182	CcSEcCtD
Prednisone—Anxiety—Carmustine—melanoma	0.000273	0.00182	CcSEcCtD
Prednisone—Paraesthesia—Bleomycin—melanoma	0.00027	0.0018	CcSEcCtD
Prednisone—Weight increased—Docetaxel—melanoma	0.00027	0.0018	CcSEcCtD
Prednisone—Convulsion—Temozolomide—melanoma	0.00027	0.00179	CcSEcCtD
Prednisone—Weight decreased—Docetaxel—melanoma	0.000269	0.00179	CcSEcCtD
Prednisone—Hypertension—Temozolomide—melanoma	0.000269	0.00179	CcSEcCtD
Prednisone—Anorexia—Dactinomycin—melanoma	0.000268	0.00178	CcSEcCtD
Prednisone—Myalgia—Temozolomide—melanoma	0.000265	0.00176	CcSEcCtD
Prednisone—Arthralgia—Temozolomide—melanoma	0.000265	0.00176	CcSEcCtD
Prednisone—Anxiety—Temozolomide—melanoma	0.000264	0.00176	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000263	0.00175	CcSEcCtD
Prednisone—Oedema—Carmustine—melanoma	0.000263	0.00175	CcSEcCtD
Prednisone—Discomfort—Temozolomide—melanoma	0.000262	0.00174	CcSEcCtD
Prednisone—Decreased appetite—Bleomycin—melanoma	0.000262	0.00174	CcSEcCtD
Prednisone—Infection—Carmustine—melanoma	0.000261	0.00174	CcSEcCtD
Prednisone—Acute coronary syndrome—Docetaxel—melanoma	0.000261	0.00174	CcSEcCtD
Prednisone—Neuropathy peripheral—Docetaxel—melanoma	0.00026	0.00173	CcSEcCtD
Prednisone—Myocardial infarction—Docetaxel—melanoma	0.00026	0.00173	CcSEcCtD
Prednisone—Tachycardia—Carmustine—melanoma	0.000257	0.00171	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000256	0.0017	CcSEcCtD
Prednisone—Oedema—Temozolomide—melanoma	0.000254	0.00169	CcSEcCtD
Prednisone—Anaphylactic shock—Temozolomide—melanoma	0.000254	0.00169	CcSEcCtD
Prednisone—Infection—Temozolomide—melanoma	0.000252	0.00168	CcSEcCtD
Prednisone—Anorexia—Carmustine—melanoma	0.000251	0.00167	CcSEcCtD
Prednisone—Nervous system disorder—Temozolomide—melanoma	0.000249	0.00166	CcSEcCtD
Prednisone—Feeling abnormal—Bleomycin—melanoma	0.000248	0.00165	CcSEcCtD
Prednisone—Skin disorder—Temozolomide—melanoma	0.000247	0.00164	CcSEcCtD
Prednisone—Hyperhidrosis—Temozolomide—melanoma	0.000246	0.00163	CcSEcCtD
Prednisone—Decreased appetite—Dactinomycin—melanoma	0.000244	0.00162	CcSEcCtD
Prednisone—Fatigue—Dactinomycin—melanoma	0.000242	0.00161	CcSEcCtD
Prednisone—Anorexia—Temozolomide—melanoma	0.000242	0.00161	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Carmustine—melanoma	0.00024	0.00159	CcSEcCtD
Prednisone—Urticaria—Bleomycin—melanoma	0.000239	0.00159	CcSEcCtD
Prednisone—Haemoglobin—Docetaxel—melanoma	0.000239	0.00159	CcSEcCtD
Prednisone—Body temperature increased—Bleomycin—melanoma	0.000238	0.00158	CcSEcCtD
Prednisone—Haemorrhage—Docetaxel—melanoma	0.000238	0.00158	CcSEcCtD
Prednisone—Insomnia—Carmustine—melanoma	0.000238	0.00158	CcSEcCtD
Prednisone—Dexamethasone—CYP17A1—melanoma	0.000237	0.177	CrCbGaD
Prednisone—Paraesthesia—Carmustine—melanoma	0.000236	0.00157	CcSEcCtD
Prednisone—Connective tissue disorder—Docetaxel—melanoma	0.000234	0.00155	CcSEcCtD
Prednisone—Feeling abnormal—Dactinomycin—melanoma	0.000231	0.00154	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000231	0.00154	CcSEcCtD
Prednisone—Insomnia—Temozolomide—melanoma	0.00023	0.00153	CcSEcCtD
Prednisone—Gastrointestinal pain—Dactinomycin—melanoma	0.00023	0.00153	CcSEcCtD
Prednisone—Decreased appetite—Carmustine—melanoma	0.000229	0.00152	CcSEcCtD
Prednisone—Paraesthesia—Temozolomide—melanoma	0.000228	0.00152	CcSEcCtD
Prednisone—Constipation—Carmustine—melanoma	0.000225	0.0015	CcSEcCtD
Prednisone—Dyspepsia—Temozolomide—melanoma	0.000224	0.00149	CcSEcCtD
Prednisone—Eye disorder—Docetaxel—melanoma	0.000222	0.00148	CcSEcCtD
Prednisone—Abdominal pain—Dactinomycin—melanoma	0.000222	0.00148	CcSEcCtD
Prednisone—Body temperature increased—Dactinomycin—melanoma	0.000222	0.00148	CcSEcCtD
Prednisone—Hypersensitivity—Bleomycin—melanoma	0.000222	0.00148	CcSEcCtD
Prednisone—Decreased appetite—Temozolomide—melanoma	0.000221	0.00147	CcSEcCtD
Prednisone—Flushing—Docetaxel—melanoma	0.000221	0.00147	CcSEcCtD
Prednisone—Fatigue—Temozolomide—melanoma	0.000219	0.00146	CcSEcCtD
Prednisone—Constipation—Temozolomide—melanoma	0.000217	0.00145	CcSEcCtD
Prednisone—Feeling abnormal—Carmustine—melanoma	0.000217	0.00144	CcSEcCtD
Prednisone—Asthenia—Bleomycin—melanoma	0.000216	0.00144	CcSEcCtD
Prednisone—Angiopathy—Docetaxel—melanoma	0.000216	0.00144	CcSEcCtD
Prednisone—Gastrointestinal pain—Carmustine—melanoma	0.000215	0.00143	CcSEcCtD
Prednisone—Immune system disorder—Docetaxel—melanoma	0.000215	0.00143	CcSEcCtD
Prednisone—Pruritus—Bleomycin—melanoma	0.000213	0.00142	CcSEcCtD
Prednisone—Arrhythmia—Docetaxel—melanoma	0.000212	0.00141	CcSEcCtD
Prednisone—Alopecia—Docetaxel—melanoma	0.00021	0.0014	CcSEcCtD
Prednisone—Feeling abnormal—Temozolomide—melanoma	0.000209	0.00139	CcSEcCtD
Prednisone—Mental disorder—Docetaxel—melanoma	0.000208	0.00139	CcSEcCtD
Prednisone—Abdominal pain—Carmustine—melanoma	0.000208	0.00138	CcSEcCtD
Prednisone—Body temperature increased—Carmustine—melanoma	0.000208	0.00138	CcSEcCtD
Prednisone—Gastrointestinal pain—Temozolomide—melanoma	0.000208	0.00138	CcSEcCtD
Prednisone—Malnutrition—Docetaxel—melanoma	0.000207	0.00138	CcSEcCtD
Prednisone—Erythema—Docetaxel—melanoma	0.000207	0.00138	CcSEcCtD
Prednisone—Hypersensitivity—Dactinomycin—melanoma	0.000207	0.00138	CcSEcCtD
Prednisone—Urticaria—Temozolomide—melanoma	0.000202	0.00134	CcSEcCtD
Prednisone—Asthenia—Dactinomycin—melanoma	0.000202	0.00134	CcSEcCtD
Prednisone—Body temperature increased—Temozolomide—melanoma	0.000201	0.00134	CcSEcCtD
Prednisone—Abdominal pain—Temozolomide—melanoma	0.000201	0.00134	CcSEcCtD
Prednisone—Hypersensitivity—Carmustine—melanoma	0.000194	0.00129	CcSEcCtD
Prednisone—Dexamethasone—NOS2—melanoma	0.000193	0.144	CrCbGaD
Prednisone—Diarrhoea—Dactinomycin—melanoma	0.000192	0.00128	CcSEcCtD
Prednisone—Vomiting—Bleomycin—melanoma	0.000191	0.00127	CcSEcCtD
Prednisone—Anaemia—Docetaxel—melanoma	0.000191	0.00127	CcSEcCtD
Prednisone—Rash—Bleomycin—melanoma	0.00019	0.00126	CcSEcCtD
Prednisone—Dermatitis—Bleomycin—melanoma	0.00019	0.00126	CcSEcCtD
Prednisone—Asthenia—Carmustine—melanoma	0.000189	0.00125	CcSEcCtD
Prednisone—Hypersensitivity—Temozolomide—melanoma	0.000187	0.00125	CcSEcCtD
Prednisone—Syncope—Docetaxel—melanoma	0.000186	0.00124	CcSEcCtD
Prednisone—Asthenia—Temozolomide—melanoma	0.000182	0.00121	CcSEcCtD
Prednisone—Loss of consciousness—Docetaxel—melanoma	0.000182	0.00121	CcSEcCtD
Prednisone—Diarrhoea—Carmustine—melanoma	0.00018	0.0012	CcSEcCtD
Prednisone—Pruritus—Temozolomide—melanoma	0.00018	0.0012	CcSEcCtD
Prednisone—Convulsion—Docetaxel—melanoma	0.000179	0.00119	CcSEcCtD
Prednisone—Nausea—Bleomycin—melanoma	0.000179	0.00119	CcSEcCtD
Prednisone—Hypertension—Docetaxel—melanoma	0.000179	0.00119	CcSEcCtD
Prednisone—Vomiting—Dactinomycin—melanoma	0.000179	0.00119	CcSEcCtD
Prednisone—Rash—Dactinomycin—melanoma	0.000177	0.00118	CcSEcCtD
Prednisone—Arthralgia—Docetaxel—melanoma	0.000176	0.00117	CcSEcCtD
Prednisone—Myalgia—Docetaxel—melanoma	0.000176	0.00117	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000175	0.00116	CcSEcCtD
Prednisone—Dizziness—Carmustine—melanoma	0.000174	0.00116	CcSEcCtD
Prednisone—Diarrhoea—Temozolomide—melanoma	0.000174	0.00116	CcSEcCtD
Prednisone—Oedema—Docetaxel—melanoma	0.000169	0.00112	CcSEcCtD
Prednisone—Anaphylactic shock—Docetaxel—melanoma	0.000169	0.00112	CcSEcCtD
Prednisone—Dizziness—Temozolomide—melanoma	0.000168	0.00112	CcSEcCtD
Prednisone—Infection—Docetaxel—melanoma	0.000168	0.00112	CcSEcCtD
Prednisone—Vomiting—Carmustine—melanoma	0.000167	0.00111	CcSEcCtD
Prednisone—Nausea—Dactinomycin—melanoma	0.000167	0.00111	CcSEcCtD
Prednisone—Shock—Docetaxel—melanoma	0.000166	0.00111	CcSEcCtD
Prednisone—Rash—Carmustine—melanoma	0.000166	0.0011	CcSEcCtD
Prednisone—Nervous system disorder—Docetaxel—melanoma	0.000166	0.0011	CcSEcCtD
Prednisone—Dermatitis—Carmustine—melanoma	0.000166	0.0011	CcSEcCtD
Prednisone—Tachycardia—Docetaxel—melanoma	0.000165	0.0011	CcSEcCtD
Prednisone—Headache—Carmustine—melanoma	0.000165	0.0011	CcSEcCtD
Prednisone—Dexamethasone—CYP1B1—melanoma	0.000164	0.122	CrCbGaD
Prednisone—Skin disorder—Docetaxel—melanoma	0.000164	0.00109	CcSEcCtD
Prednisone—Vomiting—Temozolomide—melanoma	0.000162	0.00107	CcSEcCtD
Prednisone—Anorexia—Docetaxel—melanoma	0.000161	0.00107	CcSEcCtD
Prednisone—Rash—Temozolomide—melanoma	0.00016	0.00107	CcSEcCtD
Prednisone—Dermatitis—Temozolomide—melanoma	0.00016	0.00106	CcSEcCtD
Prednisone—Headache—Temozolomide—melanoma	0.000159	0.00106	CcSEcCtD
Prednisone—Nausea—Carmustine—melanoma	0.000156	0.00104	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000154	0.00102	CcSEcCtD
Prednisone—Insomnia—Docetaxel—melanoma	0.000153	0.00102	CcSEcCtD
Prednisone—Paraesthesia—Docetaxel—melanoma	0.000152	0.00101	CcSEcCtD
Prednisone—Nausea—Temozolomide—melanoma	0.000151	0.001	CcSEcCtD
Prednisone—Dyspepsia—Docetaxel—melanoma	0.000149	0.000989	CcSEcCtD
Prednisone—Decreased appetite—Docetaxel—melanoma	0.000147	0.000977	CcSEcCtD
Prednisone—Fatigue—Docetaxel—melanoma	0.000146	0.000969	CcSEcCtD
Prednisone—Constipation—Docetaxel—melanoma	0.000144	0.000961	CcSEcCtD
Prednisone—Feeling abnormal—Docetaxel—melanoma	0.000139	0.000926	CcSEcCtD
Prednisone—Gastrointestinal pain—Docetaxel—melanoma	0.000138	0.000919	CcSEcCtD
Prednisone—Body temperature increased—Docetaxel—melanoma	0.000134	0.000889	CcSEcCtD
Prednisone—Abdominal pain—Docetaxel—melanoma	0.000134	0.000889	CcSEcCtD
Prednisone—Hypersensitivity—Docetaxel—melanoma	0.000124	0.000828	CcSEcCtD
Prednisone—Asthenia—Docetaxel—melanoma	0.000121	0.000806	CcSEcCtD
Prednisone—Pruritus—Docetaxel—melanoma	0.00012	0.000795	CcSEcCtD
Prednisone—Methylprednisolone—ABCB1—melanoma	0.000117	0.0875	CrCbGaD
Prednisone—Triamcinolone—PTGS2—melanoma	0.000117	0.0868	CrCbGaD
Prednisone—Diarrhoea—Docetaxel—melanoma	0.000116	0.000769	CcSEcCtD
Prednisone—Dizziness—Docetaxel—melanoma	0.000112	0.000743	CcSEcCtD
Prednisone—Vomiting—Docetaxel—melanoma	0.000107	0.000715	CcSEcCtD
Prednisone—Rash—Docetaxel—melanoma	0.000107	0.000709	CcSEcCtD
Prednisone—Dermatitis—Docetaxel—melanoma	0.000106	0.000708	CcSEcCtD
Prednisone—Headache—Docetaxel—melanoma	0.000106	0.000704	CcSEcCtD
Prednisone—Nausea—Docetaxel—melanoma	0.0001	0.000668	CcSEcCtD
Prednisone—Betamethasone—PTGS2—melanoma	9.54e-05	0.0711	CrCbGaD
Prednisone—Methyltestosterone—ALB—melanoma	8.81e-05	0.0656	CrCbGaD
Prednisone—Prednisolone—ABCB1—melanoma	8.28e-05	0.0617	CrCbGaD
Prednisone—Betamethasone—ABCB1—melanoma	8.11e-05	0.0604	CrCbGaD
Prednisone—Hydrocortisone—ABCB1—melanoma	6.33e-05	0.0472	CrCbGaD
Prednisone—Dexamethasone—PTGS2—melanoma	5.55e-05	0.0413	CrCbGaD
Prednisone—Dexamethasone—ABCB1—melanoma	4.72e-05	0.0351	CrCbGaD
Prednisone—SLCO1A2—Metabolism—CYP17A1—melanoma	2.71e-05	0.000269	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SYK—melanoma	2.7e-05	0.000267	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.67e-05	0.000265	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.67e-05	0.000265	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ITGAV—melanoma	2.65e-05	0.000262	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT3—melanoma	2.65e-05	0.000262	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.64e-05	0.000262	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC6A11—melanoma	2.63e-05	0.000261	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIP4K2A—melanoma	2.63e-05	0.000261	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.63e-05	0.00026	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA2—melanoma	2.59e-05	0.000256	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	2.57e-05	0.000255	CbGpPWpGaD
Prednisone—ALB—Metabolism—MTAP—melanoma	2.56e-05	0.000254	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GNA11—melanoma	2.56e-05	0.000254	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PLCB4—melanoma	2.52e-05	0.000249	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ALB—melanoma	2.51e-05	0.000249	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—FASN—melanoma	2.51e-05	0.000248	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.5e-05	0.000248	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.49e-05	0.000247	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	2.47e-05	0.000245	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HDAC2—melanoma	2.47e-05	0.000245	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC5A5—melanoma	2.47e-05	0.000244	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.46e-05	0.000244	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PLCB4—melanoma	2.45e-05	0.000243	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	2.43e-05	0.000241	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.42e-05	0.00024	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ITGB1—melanoma	2.4e-05	0.000238	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GNAQ—melanoma	2.38e-05	0.000236	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CD44—melanoma	2.38e-05	0.000236	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.37e-05	0.000235	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIP4K2A—melanoma	2.36e-05	0.000234	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC6A11—melanoma	2.36e-05	0.000234	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ACER3—melanoma	2.35e-05	0.000233	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.33e-05	0.000231	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.31e-05	0.000229	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC6A11—melanoma	2.31e-05	0.000229	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIP4K2A—melanoma	2.31e-05	0.000229	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MTAP—melanoma	2.3e-05	0.000228	CbGpPWpGaD
Prednisone—ALB—Metabolism—PHGDH—melanoma	2.28e-05	0.000226	CbGpPWpGaD
Prednisone—ALB—Metabolism—LUM—melanoma	2.28e-05	0.000226	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1B1—melanoma	2.28e-05	0.000226	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.25e-05	0.000223	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.25e-05	0.000223	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MTAP—melanoma	2.25e-05	0.000223	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.24e-05	0.000222	CbGpPWpGaD
Prednisone—ALB—Metabolism—HPSE—melanoma	2.24e-05	0.000222	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	2.23e-05	0.000221	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HGF—melanoma	2.2e-05	0.000218	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.2e-05	0.000218	CbGpPWpGaD
Prednisone—ALB—Metabolism—CUBN—melanoma	2.2e-05	0.000218	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CSF2—melanoma	2.17e-05	0.000216	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—UGT2B10—melanoma	2.15e-05	0.000213	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.14e-05	0.000212	CbGpPWpGaD
Prednisone—ALB—Metabolism—SDHD—melanoma	2.12e-05	0.00021	CbGpPWpGaD
Prednisone—ALB—Metabolism—CSPG4—melanoma	2.12e-05	0.00021	CbGpPWpGaD
Prednisone—ALB—Metabolism—BSG—melanoma	2.12e-05	0.00021	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.12e-05	0.00021	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ITGB3—melanoma	2.08e-05	0.000207	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PRKCA—melanoma	2.08e-05	0.000207	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.07e-05	0.000205	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.07e-05	0.000205	CbGpPWpGaD
Prednisone—ALB—Metabolism—GPAM—melanoma	2.06e-05	0.000204	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.06e-05	0.000204	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—LUM—melanoma	2.05e-05	0.000203	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PHGDH—melanoma	2.05e-05	0.000203	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.01e-05	0.0002	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HPSE—melanoma	2.01e-05	0.000199	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PHGDH—melanoma	2e-05	0.000198	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—LUM—melanoma	2e-05	0.000198	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HS3ST5—melanoma	2e-05	0.000198	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CUBN—melanoma	1.97e-05	0.000196	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CDKN2B—melanoma	1.97e-05	0.000195	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HPSE—melanoma	1.96e-05	0.000195	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.96e-05	0.000194	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAC1—melanoma	1.93e-05	0.000192	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CUBN—melanoma	1.93e-05	0.000191	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—VDR—melanoma	1.92e-05	0.000191	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SDHD—melanoma	1.91e-05	0.000189	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BSG—melanoma	1.91e-05	0.000189	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CSPG4—melanoma	1.91e-05	0.000189	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.89e-05	0.000188	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ABCB1—melanoma	1.88e-05	0.000186	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MMP1—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.87e-05	0.000185	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CSPG4—melanoma	1.86e-05	0.000184	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BSG—melanoma	1.86e-05	0.000184	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SDHD—melanoma	1.86e-05	0.000184	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GPAM—melanoma	1.85e-05	0.000183	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CDK2—melanoma	1.84e-05	0.000182	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GPAM—melanoma	1.8e-05	0.000179	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.79e-05	0.000178	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PRKCA—melanoma	1.77e-05	0.000176	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.76e-05	0.000175	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ERCC2—melanoma	1.76e-05	0.000174	CbGpPWpGaD
Prednisone—ALB—Metabolism—PLA2G6—melanoma	1.75e-05	0.000173	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PRKCA—melanoma	1.73e-05	0.000171	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.72e-05	0.00017	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ERCC2—melanoma	1.72e-05	0.00017	CbGpPWpGaD
Prednisone—ALB—Hemostasis—FN1—melanoma	1.71e-05	0.000169	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.71e-05	0.000169	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS2—melanoma	1.69e-05	0.000167	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.68e-05	0.000166	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.68e-05	0.000166	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—melanoma	1.63e-05	0.000162	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EGF—melanoma	1.61e-05	0.00016	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.6e-05	0.000158	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.59e-05	0.000157	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.59e-05	0.000157	CbGpPWpGaD
Prednisone—ALB—Metabolism—VCAN—melanoma	1.57e-05	0.000156	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PLA2G6—melanoma	1.57e-05	0.000156	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PLA2G6—melanoma	1.53e-05	0.000152	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLCB4—melanoma	1.51e-05	0.00015	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IGF1—melanoma	1.5e-05	0.000148	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.49e-05	0.000147	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.48e-05	0.000147	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.46e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CD—melanoma	1.44e-05	0.000142	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.43e-05	0.000142	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.42e-05	0.000141	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC6A11—melanoma	1.42e-05	0.000141	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.42e-05	0.000141	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH1—melanoma	1.42e-05	0.000141	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—VCAN—melanoma	1.41e-05	0.00014	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.41e-05	0.00014	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTAP—melanoma	1.38e-05	0.000137	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—VCAN—melanoma	1.38e-05	0.000136	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—melanoma	1.36e-05	0.000134	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARG—melanoma	1.34e-05	0.000133	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.33e-05	0.000132	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP17A1—melanoma	1.33e-05	0.000131	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARG—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.31e-05	0.00013	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.29e-05	0.000128	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNA11—melanoma	1.25e-05	0.000124	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—melanoma	1.25e-05	0.000124	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PHGDH—melanoma	1.23e-05	0.000122	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—LUM—melanoma	1.23e-05	0.000122	CbGpPWpGaD
Prednisone—ALB—Metabolism—FASN—melanoma	1.22e-05	0.000121	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HPSE—melanoma	1.21e-05	0.00012	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.21e-05	0.00012	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A5—melanoma	1.2e-05	0.000119	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—melanoma	1.19e-05	0.000118	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.19e-05	0.000118	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP17A1—melanoma	1.19e-05	0.000118	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CUBN—melanoma	1.19e-05	0.000118	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALB—melanoma	1.18e-05	0.000117	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.17e-05	0.000116	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNAQ—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Prednisone—ALB—Metabolism—CD44—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP17A1—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.16e-05	0.000115	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—melanoma	1.15e-05	0.000114	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SDHD—melanoma	1.15e-05	0.000114	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BSG—melanoma	1.15e-05	0.000114	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CSPG4—melanoma	1.15e-05	0.000114	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.14e-05	0.000113	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.13e-05	0.000112	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNA11—melanoma	1.12e-05	0.000111	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1B1—melanoma	1.12e-05	0.000111	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPAM—melanoma	1.11e-05	0.00011	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—FASN—melanoma	1.1e-05	0.000109	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNA11—melanoma	1.1e-05	0.000109	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A5—melanoma	1.08e-05	0.000107	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.07e-05	0.000107	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—FASN—melanoma	1.07e-05	0.000106	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A5—melanoma	1.06e-05	0.000105	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNAQ—melanoma	1.04e-05	0.000104	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CD44—melanoma	1.04e-05	0.000104	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—melanoma	1.04e-05	0.000103	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—melanoma	1.03e-05	0.000102	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.02e-05	0.000101	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CD44—melanoma	1.02e-05	0.000101	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNAQ—melanoma	1.02e-05	0.000101	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.01e-05	0.0001	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1B1—melanoma	1e-05	9.92e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.84e-06	9.76e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1B1—melanoma	9.77e-06	9.69e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—melanoma	9.77e-06	9.68e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—melanoma	9.65e-06	9.56e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLA2G6—melanoma	9.44e-06	9.36e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK3—melanoma	9.24e-06	9.16e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCB1—melanoma	9.18e-06	9.1e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—melanoma	8.97e-06	8.89e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.84e-06	8.76e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK1—melanoma	8.79e-06	8.71e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—VCAN—melanoma	8.48e-06	8.4e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PRKCA—melanoma	8.45e-06	8.38e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ERCC2—melanoma	8.38e-06	8.31e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—melanoma	8.3e-06	8.23e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCB1—melanoma	8.25e-06	8.17e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MAPK3—melanoma	7.86e-06	7.79e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—melanoma	7.64e-06	7.57e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—melanoma	7.63e-06	7.56e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PRKCA—melanoma	7.59e-06	7.52e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ERCC2—melanoma	7.53e-06	7.46e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PRKCA—melanoma	7.41e-06	7.34e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—melanoma	7.38e-06	7.31e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ERCC2—melanoma	7.35e-06	7.28e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP17A1—melanoma	7.15e-06	7.09e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—melanoma	7.06e-06	7e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.94e-06	6.88e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNA11—melanoma	6.76e-06	6.7e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—melanoma	6.62e-06	6.56e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—FASN—melanoma	6.61e-06	6.55e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A5—melanoma	6.5e-06	6.45e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARG—melanoma	6.39e-06	6.33e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—melanoma	6.33e-06	6.27e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNAQ—melanoma	6.28e-06	6.23e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CD44—melanoma	6.28e-06	6.23e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.23e-06	6.18e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—melanoma	6.23e-06	6.18e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1B1—melanoma	6.02e-06	5.97e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—melanoma	5.94e-06	5.89e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—melanoma	5.82e-06	5.77e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—melanoma	5.8e-06	5.75e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARG—melanoma	5.74e-06	5.69e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARG—melanoma	5.6e-06	5.55e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—melanoma	5.3e-06	5.25e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—melanoma	5.22e-06	5.18e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—melanoma	5.17e-06	5.13e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALB—melanoma	5.16e-06	5.11e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—melanoma	5.1e-06	5.06e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—melanoma	5.07e-06	5.03e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALB—melanoma	5.03e-06	4.99e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—melanoma	5.03e-06	4.98e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCB1—melanoma	4.96e-06	4.91e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PRKCA—melanoma	4.56e-06	4.52e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—melanoma	4.55e-06	4.51e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ERCC2—melanoma	4.53e-06	4.49e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—melanoma	4.51e-06	4.47e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—melanoma	4.45e-06	4.41e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—melanoma	4.4e-06	4.37e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—melanoma	4.38e-06	4.35e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—melanoma	3.94e-06	3.9e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—melanoma	3.84e-06	3.81e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—melanoma	3.57e-06	3.54e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARG—melanoma	3.45e-06	3.42e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—melanoma	3.14e-06	3.11e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALB—melanoma	3.1e-06	3.07e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—melanoma	3.09e-06	3.07e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—melanoma	2.78e-06	2.75e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—melanoma	2.74e-06	2.71e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—melanoma	2.71e-06	2.69e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—melanoma	2.71e-06	2.69e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—melanoma	2.53e-06	2.5e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—melanoma	2.37e-06	2.35e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—melanoma	2.27e-06	2.25e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—melanoma	2.21e-06	2.19e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—melanoma	1.67e-06	1.65e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—melanoma	1.36e-06	1.35e-05	CbGpPWpGaD
